Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


Articles published in Thyroid

Retrieve available abstracts of 162 articles:
HTML format
Text format



Single Articles


    September 2017
  1. YAPA S, Mulla O, Green V, England J, et al
    The Role of Chemokines in Thyroid Carcinoma.
    Thyroid. 2017 Sep 11. doi: 10.1089/thy.2016.0660.
    PubMed     Text format     Abstract available


  2. RUIZ-FERRER M, Fernandez RM, Navarro E, Antinolo G, et al
    <i>ESR2</i> gene and Medullary Thyroid Carcinoma.
    Thyroid. 2017 Sep 11. doi: 10.1089/thy.2017.0171.
    PubMed     Text format     Abstract available


    August 2017
  3. CHINN SB, Zafereo M, Waguespack SG, Edeiken BS, et al
    Long-term outcomes of lateral neck dissection in patients with recurrent or persistent well-differentiated thyroid cancer.
    Thyroid. 2017 Aug 15. doi: 10.1089/thy.2017.0203.
    PubMed     Text format     Abstract available


    July 2017
  4. HAHN SY, Shin JH, Oh YL, Kim TH, et al
    Role of Ultrasound in Predicting Tumor Invasiveness in Follicular Variant of Papillary Thyroid Carcinoma.
    Thyroid. 2017 Jul 12. doi: 10.1089/thy.2016.0677.
    PubMed     Text format     Abstract available


    June 2017
  5. ITO Y, Onoda N, Ito KI, Sugitani I, et al
    Sorafenib in Japanese Patients With Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.
    Thyroid. 2017 Jun 21. doi: 10.1089/thy.2016.0621.
    PubMed     Text format     Abstract available


    May 2017
  6. HEDMAN C, Djarv T, Strang P, Lundgren CI, et al
    The effect of thyroid-related symptoms on long-term quality of life in patients with differentiated thyroid carcinoma - a population-based study in Sweden.
    Thyroid. 2017 May 5. doi: 10.1089/thy.2016.0604.
    PubMed     Text format     Abstract available


  7. KIM M, Kim WG, Park S, Kwon H, et al
    Growth Kinetics of Macronodular Lung Metastases and Survival in Differentiated Thyroid Carcinoma.
    Thyroid. 2017 May 2. doi: 10.1089/thy.2016.0676.
    PubMed     Text format     Abstract available


    April 2017
  8. OH HS, Kim WG, Park S, Kim M, et al
    Serial neck ultrasonographic evaluation of changes in papillary thyroid carcinoma during pregnancy.
    Thyroid. 2017 Apr 27. doi: 10.1089/thy.2016.0618.
    PubMed     Text format     Abstract available


  9. KIM H, Kim TH, Choe JH, Kim JH, et al
    Patterns of initial recurrence in completely resected papillary thyroid carcinoma.
    Thyroid. 2017 Apr 27. doi: 10.1089/thy.2016.0648.
    PubMed     Text format     Abstract available


  10. YANG Z, Flores J, Katz S, Nathan CA, et al
    Comparison of survival outcomes following post-surgical radioactive iodine versus external beam radiation in stage IV differentiated thyroid carcinoma.
    Thyroid. 2017 Apr 27. doi: 10.1089/thy.2016.0650.
    PubMed     Text format     Abstract available


    March 2017
  11. BONHOMME B, Godbert Y, Perot G, Alghuzlan A, et al
    Molecular pathology of anaplastic thyroid carcinomas: a retrospective study of 144 cases.
    Thyroid. 2017 Mar 28. doi: 10.1089/thy.2016.0254.
    PubMed     Text format     Abstract available


  12. TAVARELLI M, Sarfati J, Chereau N, Tissier F, et al
    Heterogeneous prognoses for pT3 papillary thyroid carcinomas and impact of delayed risk stratification.
    Thyroid. 2017 Mar 28. doi: 10.1089/thy.2016.0512.
    PubMed     Text format     Abstract available


  13. LEE SE, Hwang TS, Choi YL, Kim WY, et al
    Molecular profiling of papillary thyroid carcinoma in Korea with high prevalence of BRAF V600E mutation.
    Thyroid. 2017 Mar 15. doi: 10.1089/thy.2016.0547.
    PubMed     Text format     Abstract available


  14. CIPRIANI NA, Agarwal S, Dias-Santagata D, Faquin WC, et al
    Clear cell change in thyroid carcinoma: a clinicopathologic and molecular study with identification of variable genetic anomalies.
    Thyroid. 2017 Mar 15. doi: 10.1089/thy.2016.0631.
    PubMed     Text format     Abstract available


    January 2017
  15. PAEPEGAEY AC, Cochand-Priollet B, Louiset E, Sarfati PO, et al
    Long-term control of hypercortisolism by vandetanib in a medullary thyroid carcinoma with a somatic RET mutation.
    Thyroid. 2017 Jan 9. doi: 10.1089/thy.2016.0334.
    PubMed     Text format     Abstract available


  16. RAO SN, Zafereo M, Dadu R, Busaidy N, et al
    Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma.
    Thyroid. 2017 Jan 9. doi: 10.1089/thy.2016.0395.
    PubMed     Text format     Abstract available


  17. VAN DER WARDT RA, Persoon AC, Klein Hesselink EN, Links TP, et al
    Long-term follow-up for differentiated thyroid carcinoma patients - a reconsideration.
    Thyroid. 2017 Jan 3. doi: 10.1089/thy.2016.0314.
    PubMed     Text format     Abstract available


  18. XU B, Tuttle RM Md, Sabra M, Ganly I, et al
    Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinico-Pathologic and Molecular Characteristics.
    Thyroid. 2017 Jan 3. doi: 10.1089/thy.2016.0582.
    PubMed     Text format     Abstract available


    November 2016
  19. CORDIOLI MI, Moraes L, Bastos AU, Besson P, et al
    Fusion oncogenes are the main genetic events found in sporadic papillary thyroid carcinomas from children.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  20. LUBITZ CC, De Gregorio L, Fingeret AL, Economopoulos KP, et al
    Measurement and Variation in Estimation of Quality of Life Effects of Patients Undergoing Treatment for Papillary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  21. NIKITSKI A, Rogounovitch T, Bychkov A, Takahashi M, et al
    Genotype analyses in the Japanese and Belarusian populations reveal independent effects of rs965513 and rs1867277 but do not support the role of FOXE1 polyalanine tract length in conferring risk for papillary thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    October 2016
  22. WEINBERGER P, Ponny SR, Xu H, Bai S, et al
    Cell Cycle M-phase Genes are Highly Upregulated in Anaplastic Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  23. SANDULACHE VC, Williams MD, Lai SY, Lu C, et al
    Real-time genomic characterization utilizing circulating cell-free DNA in patients with anaplastic thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  24. KIM SK, Park I, Hur N, Lee JH, et al
    Should Level V Be Routinely Dissected in N1b Papillary Thyroid Carcinoma?
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  25. CORREA NL, de Sa LV, Corbo R
    Estimation of second primary cancer risk after treatment with radioactive iodine for differentiated thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  26. LANG BH, Shek T, Chan AO, Lo CY, et al
    Significance of size of persistent/recurrent central nodal disease on surgical morbidity and response to therapy in reoperative neck dissection for papillary thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  27. KIM SK, Park I, Woo JW, Lee JH, et al
    Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size < 4 cm.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  28. KIM M, Kim WG, Park S, Kwon H, et al
    The Initial Size of Metastatic Lesions is the Best Prognostic Factor in Patients with Metastatic Differentiated Thyroid Carcinoma Confined to the Lung.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  29. HONG S, Yu S, Li J, Yin Y, et al
    MiR-20b Displays Tumor Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    September 2016
  30. XU JY, Grubbs EG, Waguespack SG, Jimenez C, et al
    Medullary Thyroid Carcinoma Associated with Germline RET K666N Mutation.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  31. TOMODA C, Sugino K, Matsuzu K, Uruno T, et al
    Cervical lymph node metastases after thyroidectomy for papillary thyroid carcinoma usually remain stable for years.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  32. GRUBBS EG, Williams MD, Scheet P, Vattathil S, et al
    The role of CDKN2C copy number in sporadic medullary thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  33. PANKRATZ DG, Hu Z, Kim SY, Monroe RJ, et al
    Analytical Performance of a Gene Expression Classifier for Medullary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  34. ESSIG G JR, Porter K, Schneider DF, Arpaia D, et al
    MULTIFOCALITY IN SPORADIC MEDULLARY THYROID CARCINOMA: AN INTERNATIONAL MULTICENTER STUDY.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    August 2016
  35. DA FONSECA FL, Yamanaka PK, Kato JM, Matayoshi S, et al
    LACRIMAL SYSTEM OBSTRUCTION AFTER RADIOIODINE THERAPY IN DIFFERENTIATED THYROID CARCINOMAS: A PROSPECTIVE COMPARATIVE STUDY.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  36. SCHEFFEL RS, Zanella AB, Dora JM, Maia AL, et al
    Timing of radioactive iodine administration does not influence outcomes in patients with differentiated thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  37. PRAGER G, Koperek O, Mayerhofer M, Muellauer L, et al
    Sustained Response to Vemurafenib in an BRAF V600E-mutated Anaplastic Thyroid Carcinoma Patient.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  38. LIKHTEROV I, Osorio M, Moubayed SP, Hernandez-Prera J, et al
    The Ethical Implications of the Reclassification of Non Invasive-Follicular Variant Papillary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  39. XU B, Ibrahimpasic T, Wang LY, Sabra M, et al
    Clinico-Pathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    July 2016
  40. KIM SH, Roh JL, Gong G, Cho KJ, et al
    Differences in the Recurrence and Survival of Patients with Symptomatic and Asymptomatic Papillary Thyroid Carcinoma: An Observational Study of 11,265 Person-Years of Follow-up.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  41. LEE DY, Won JK, Choi HS, Park DJ, et al
    Recurrence and survival after gross total removal of resectable undifferentiated or poorly differentiated thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  42. OPSAHL EM, Schlichting E, Helset K, Svartberg J, et al
    A Nationwide study of multiple endocrine neoplasia type 2A in Norway. Predictive avd prognostic factors for the clinical course of medullary thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  43. ATALLAH V, Hocquelet A, Do Cao C, Zerdoud S, et al
    Activity and safety of Sunitinib in patients with advanced radio-iodine refractory thyroid carcinoma: a retrospective analysis of 57 patients.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    June 2016
  44. JENDRZEJEWSKI JP, Liyanarachchi S, Nagy R, Senter L, et al
    Papillary thyroid carcinoma: Association between germline DNA variant markers and clinical parameters.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  45. KIM SK, Park I, Woo JW, Lee JH, et al
    Follicular and Diffuse Sclerosing Variant Papillary Thyroid Carcinomas as Independent Predictive Factors of Loco-regional Recurrence: A Comparison Study Using Propensity Score Matching.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  46. VALDERRABANO P, Klippenstein DL, Tourtelot JB, Ma Z, et al
    The new ATA sonographic patterns for thyroid nodules perform well in medullary thyroid carcinoma: Institutional experience, systematic review and meta-analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    May 2016
  47. WONG KS, Angell TE, Strickland KC, Alexander EK, et al
    Noninvasive Follicular Variant of Papillary Thyroid Carcinoma and the Afirma Gene-Expression Classifier.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  48. DANIELS GH
    Follicular Variant of Papillary Thyroid Carcinoma: Hybrid or Mixture.
    Thyroid. 2016.
    PubMed     Text format    


  49. LEE SE, Hwang TS, Choi YL, Han HS, et al
    Prognostic significance of TERT promoter mutations in papillary thyroid carcinomas in a BRAF V600E mutation-prevalent population.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    April 2016
  50. DU E, Wenig B, Su HK, Rowe ME, et al
    Inter-observer Variation in the Pathologic Identification of Extranodal Extension in Nodal Metastasis from Papillary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    March 2016
  51. LATROFA F, Ricci D, Sisti E, Piaggi P, et al
    Significance of low levels of thyroglobulin autoantibodies associated with undetectable thyroglobulin after thyroidectomy for differentiated thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  52. JEON M, Chun SM, Kim D, Kwon H, et al
    Genomic alterations of anaplastic thyroid carcinoma detected by targeted massive parallel sequencing in a BRAFV600E mutation-prevalent area.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  53. KIM SK, Woo JW, Park I, Lee JH, et al
    Influence of Body Mass Index and Body Surface Area on the Behavior of Papillary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  54. LEE YH, Seo HS, Suh SI, Ryoo I, et al
    A Feasibility Study of a Contrast-Enhanced Multi-detector CT (64 channels) Protocol for Papillary Thyroid Carcinoma: The Influence of Different Scan Delays on Tumor Conspicuity.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  55. SU HK, Wenig B, Haser GC, Rowe ME, et al
    Inter-observer Variation in the Pathologic Identification of Minimal Extrathyroidal Extension in Papillary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  56. ARAGON HAN P, Kim HS, Cho S, Fazeli R, et al
    Association of BRAF Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    February 2016
  57. LIN JD, Fu SS, Chen JY, Lee CH, et al
    Clinical Manifestations and Gene Expression in Patients with Conventional Papillary Thyroid Carcinoma Carrying the BRAFV600E Mutation and BRAF Pseudogene.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  58. NIXON IJ, Wang LY, Migliacci JC, Eskander A, et al
    An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  59. URKEN ML, Haser GC, Likhterov I, Wenig B, et al
    The impact of metastatic lymph nodes on risk stratification in differentiated thyroid cancer: Have we reached a higher level of understanding?
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  60. KOWALSKA A, Walczyk A, Kowalik A, Palyga I, et al
    Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF Mutation: A Single-Institution Study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  61. SABRA MM, Ghossein R, Tuttle RM
    Time Course and Predictors of Structural Disease Progression in Pulmonary Metastases Arising from Follicular Cell-Derived Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  62. GANDHI A, Wong KK, Gross M, Avram A, et al
    Lingual Thyroid Ectopia: Diagnostic SPECT/CT imaging and Radioactive Iodine Treatment.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  63. BERBER E, Bernet V, Fahey T 3rd, Kebebew E, et al
    American Thyroid Association Statement on Remote Access Thyroid Surgery.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  64. GULEC SA, Kuker RA, Goryawala M, Fernandez C, et al
    I-124 PET/CT IN PATIENTS WITH DIFFERENTIATED THYROID CANCER: CLINICAL AND QUANTITATIVE IMAGE ANALYSIS.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  65. BAKKAR S, Frustaci G, Papini P, Fregoli L, et al
    Track Recurrence After Robotic Transaxillary Thyroidectomy; A Case Report Highlighting The Importance of Controlled Surgical Indications and Addressing Unprecedented Complications.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  66. GRECO A, Albanese S, Auletta L, Mirabelli P, et al
    High-frequency ultrasound-guided injection for the generation of a novel orthotopic mouse model of human thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  67. ROSARIO PW, Carvalho M, Mourao GF, Calsolari MR, et al
    Comparison of antithyroglobulin antibodies concentrations before and after ablation with 131I as predictor of structural disease in differentiated thyroid carcinoma patients with undetectable basal thyroglobulin and negative neck ultrasonography.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  68. BALACHANDAR S, La Quaglia M, Tuttle RM, Heller G, et al
    Pediatric Differentiated Thyroid Carcinoma of Follicular Cell Origin: Prognostic Significance of Histologic Subtypes.
    Thyroid. 2016;26:219-26.
    PubMed     Text format     Abstract available


    January 2016
  69. HEATON CM, Chang JL, Orloff LA
    Prognostic implications of lymph node yield in central and lateral neck dissections for well-differentiated papillary thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  70. SUH CH, Baek JH, Choi YJ, Lee JH, et al
    Efficacy and safety of radiofrequency and ethanol ablation for treating locally recurrent thyroid cancer: A systematic review and meta-analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  71. KITAHARA CM, McCullough M, Franceschi S, Rinaldi S, et al
    Anthropometric factors and thyroid cancer risk by histological subtype: pooled analysis of 22 prospective studies.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  72. ANGELL TE, Lechner MG, Smith AM, Martin SE, et al
    Circulating Myeloid Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  73. NA DG, Baek JH, Sung JY, Kim JH, et al
    Thyroid Imaging Reporting and Data System for Risk Stratification of Thyroid Nodules: Categorization Based on Solidity and Echogenicity.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  74. AHN HY, Chung YJ, Park KY, Cho BY, et al
    Serum 25-Hydroxyvitamin D Level Does Not Affect the Aggressiveness and Prognosis of Papillary Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  75. BRITO JP, Ito Y, Miyauchi A, Tuttle RM, et al
    A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.
    Thyroid. 2016;26:144-9.
    PubMed     Text format     Abstract available


    December 2015
  76. LEE L, Mitmaker EJ, Chabot JA, Lee JA, et al
    Cost-Effectiveness of Diagnostic Lobectomy Versus Observation for Thyroid Nodules Greater than 4 cm.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  77. ALZAHRANI AS, Qasem E, Murugan AK, Al-Hindi HN, et al
    Uncommon TERT Promoter Mutations in Pediatric Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  78. CASTRONEVES LA, Negrao MV, Freitas RM, Papadia C, et al
    Sorafenib for the treatment of Progressive Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  79. SAWKA AM, Brierley J, Tsang RW, Rotstein L, et al
    Unmet Information Needs of Low Risk Thyroid Cancer Survivors.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  80. CHEN Y, Sadow PM, Suh H, Lee KE, et al
    BRAFV600E is correlated with recurrence of papillary thyroid microcarcinoma: A systematic review, multi-institutional primary data analysis, and meta-analysis.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  81. ITO Y, Miyauchi A, Kudo T, Ota H, et al
    Effects of Pregnancy on Papillary Microcarcinomas of the Thyroid Re-Evaluated in the Entire Patient Series at Kuma Hospital.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  82. SUH CH, Baek JH, Lee JH, Choi YJ, et al
    The role of core-needle biopsy as a first-line diagnostic tool for initially detected thyroid nodules.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  83. BIKAS A, Van Nostrand D, Jensen KE, Desale S, et al
    Metformin Attenuates <sup>131</sup>I - Induced Decrease in Peripheral Blood Cells in Patients with Differentiated Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  84. NIKITA ME, Jiang W, Cheng SM, Hantash FM, et al
    Mutational analysis in Pediatric Thyroid Cancer and correlations with age, ethnicity and clinical presentation.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    November 2015
  85. PITOIA F, Miyauchi A
    2015 American Thyroid Association Guidelines for Thyroid Nodules and Differentiated Thyroid Cancer and their Implementation in Various Care Settings.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  86. KIM JW, Roh JL, Gong G, Cho KJ, et al
    Treatment Outcomes and Risk Factors for Recurrence after Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  87. ESPIARD S, Petyt G, Lion G, Beron A, et al
    Ectopic Subcutaneous Implantation of Thyroid Tissue after Gasless Transaxillary Robotic Thyroidectomy for Papillary Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  88. JEON M, Kim WG, Choi YM, Kwon H, et al
    Features predictive of distant metastasis in papillary thyroid microcarcinoma.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  89. LIU X, Medici M, Kwong N, Angell TE, et al
    Bethesda Categorization of Thyroid Nodule Cytology & Prediction of Thyroid Cancer Type and Prognosis.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  90. BERNARDI S, Lanzilotti V, Papa G, Panizzo N, et al
    Full-thickness skin burn caused by radiofrequency ablation of a benign thyroid nodule.
    Thyroid. 2015.
    PubMed     Text format    


  91. DE NAPOLI L, Bakkar S, Ambrosini CE, Materazzi G, et al
    Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    October 2015
  92. HAUGEN BR MD, Alexander EK, Bible KC, Doherty G, et al
    2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  93. COURA-FILHO GB, Carvalho JW, Buchpiguel CA, Sapienza MT, et al
    Effects of thyroid hormone withdrawal and recombinant human TSH on glomerular filtration rate during radioiodine therapy for well-differentiated thyroid cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  94. AN JH, Yul H, Ahn HY, Keam B, et al
    A Possible Association Between Thyroid Cancer and Breast Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  95. CHOI YJ, Baek JH, Baek S, Shim WH, et al
    Web-based Malignancy Risk Estimation for Thyroid Nodules using Ultrasonography Characteristics: Development and Validation of a Predictive Model.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  96. KHOKHAR MT, Day KM, Sangal RB, Ahmedli NM, et al
    Preoperative High-Resolution Ultrasound for the Assessment of Malignant Central Compartment Lymph Nodes In Papillary Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  97. ASCHEBROOK-KILFOY B, James BC, Nagar S, Kaplan S, et al
    Risk Factors for Decreased Quality of Life in Thyroid Cancer Survivors: Initial Findings from the North American Thyroid Cancer Survivorship Study.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  98. PATEL DT, Kitahara CM, Park Y, Liao LM, et al
    Thyroid Cancer and Nonsteroidal Antiinflammatory Drug Use: A Pooled Analysis of Patients Over 40 years of Age.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  99. ODA H, Miyauchi A, Ito Y, Yoshioka K, et al
    Incidences of Unfavorable Events in the Management of Low-risk Papillary Microcarcinoma of the Thyroid by Active Surveillance vs. Immediate Surgery.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    September 2015
  100. FAN N, Talaga M, Brown R, Fueri A, et al
    Glycan-dependent mutual and reversible sequestration of two thyroid cancer biomarkers.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  101. COYNE C, Afkhami M, Karunamurthy A, Chiosea SI, et al
    Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAF K601E Mutation.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  102. ARAGON HAN P, Weng CH, Khawaja HT, Nagarajan N, et al
    MicroRNA Expression and Association with Clinicopathologic Features in Papillary Thyroid Cancer: A Systematic Review.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  103. DANILOVIC DL, de Camargo RY, Castro G Jr, Papadia C, et al
    Rapid Control of T3 Thyrotoxicosis in Patients with Metastatic Follicular Thyroid Cancer Treated with Lenvatinib.
    Thyroid. 2015.
    PubMed     Text format    


  104. ATKINS F, Van Nostrand D, Moreau S, Burman K, et al
    Validation of a Simple Thyroid Cancer Dosimetry Model Based on the Fractional Whole-Body Retention at 48 Hours Post-Administration of I.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  105. FERRIS RL, Carty SE
    Response to Letter to the Editor on COI for American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules.
    Thyroid. 2015.
    PubMed     Text format    


  106. NIKIFOROV YE, Carty SE, Chiosea SI, Coyne C, et al
    Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  107. SHRESTHA RT, Karunamurthy A, Amin K, Nikiforov YE, et al
    Multiple Mutations Detected Preoperatively May Predict Aggressive Behavior of Papillary Thyroid Cancer and Guide Management - A Case Report.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  108. KLOOS RT, Kennedy GC
    Response to "American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making".
    Thyroid. 2015.
    PubMed     Text format    


  109. KIM D, Hwang SH, Cha J, Jo K, et al
    Risk Stratification of Thyroid Incidentalomas Found on PET/CT: The Value of Iodine Content on Noncontrast Computed Tomography.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    August 2015
  110. TOLEDO RA, Maciel RM, Erlic Z, Lourenco DM Jr, et al
    RET Y791F Variant Does Not Increase the Risk for Medullary Thyroid Carcinoma.
    Thyroid. 2015;25:973-4.
    PubMed     Text format    


    July 2015
  111. MCLEOD DS, Jonklaas J, Brierley J, Ain KB, et al
    Reassessing the NTCTCS staging systems for differentiated thyroid cancer, including age at diagnosis.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  112. DADU R, Hu MI, Cleeland CS, Busaidy N, et al
    The efficacy of the natural clay, Calcium Aluminosilicate Anti-Diarrheal (CASAD), in reducing medullary thyroid cancer-related diarrhea and its effects on quality of life: a pilot study.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  113. SINGH OSPINA NM, Sebo TJ, Morris JC 3rd, Castro MR, et al
    The value of repeat thyroid fine needle aspiration biopsy in patients with a previously benign result: How often does it alter management?
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  114. AL AFIF A, Williams BA, Rigby MH, Bullock M, et al
    Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  115. GANLY I, Nixon IJ, Wang LY, Palmer FL, et al
    Survival from differentiated thyroid cancer What has age got to do with it?
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  116. ROSARIO PW, Calsolari MR
    What is the best criterion for repetition of fine-needle aspiration in thyroid nodules with initially benign cytology?
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  117. DE BIASE D, Gandolfi G, Ragazzi M, Eszlinger M, et al
    TERT PROMOTER MUTATIONS IN THYROID PAPILLARY MICROCARCINOMAS.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  118. SEO GH, Cho YY, Chung JH, Kim SW, et al
    Increased Risk of Leukemia After Radioactive Iodine Therapy in Patients with Thyroid Cancer: A Nationwide, Population-Based Study in Korea.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  119. WIEBEL JL, Esfandiari NH, Papaleontiou M, Worden FP, et al
    Evaluating Positron Emission Tomography Use in Differentiated Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  120. VACCARELLA S, Dal Maso L, Laversanne M, Bray F, et al
    The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  121. LARRIVEE-VANIER S, Magne F, Patey N, Chanoine JP, et al
    Conserved telomere length in human ectopic thyroids: an argument against premature differentiation causing arrested migration.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  122. PITOIA F, Jerkovich F, Urciuoli C, Schmidt A, et al
    Implementing the Modified 2009 American Thyroid Association Risk Stratification System in thyroid cancer patients with low and intermediate risk of recurrence.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  123. RALHAN R, Veyhl J, Chaker S, Assi J, et al
    Immunohistochemical Subcellular Localization of Protein Biomarkers Distinguishes Benign from Malignant Thyroid Nodules: Potential for Fine Needle Aspiration Biopsy Clinical Application.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    June 2015
  124. WANG LY, Ghossein R Md, Palmer FL, Nixon IJ, et al
    Microscopic Positive Margins in differentiated thyroid cancer is not an independent predictor of local failure.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  125. BRITO JP, AlNofal A, Montori V, Hay ID, et al
    The impact of subclinical disease and mechanism of detection on the rise in thyroid cancer incidence: a population-based study in Olmsted County, Minnesota during 1935 through 2012.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    May 2015
  126. HINSON AM, Kandil E, O'Brien S, Spencer HJ, et al
    Trends in Robotic Thyroid Surgery in the United States from 2009 through 2013.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  127. DEANDREA M, Sung JY, Limone PP, Mormile A, et al
    Efficacy and Safety of Radiofrequency Ablation versus Control Condition for Nonfunctioning Benign Thyroid Nodules: A Randomized Controlled International Collaborative Trial.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  128. FERRIS RL, Baloch ZW, Bernet V, Chen A, et al
    American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: current impact on perioperative decision-making.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  129. CHOI SH, Baek JH, Lee JH, Choi YJ, et al
    Evaluation of the clinical usefulness of BRAFV600E mutation analysis of core-needle biopsy specimens in thyroid nodules with previous atypia of undetermined significance (AUS) or follicular lesions of undetermined significance (FLUS) results.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  130. MARTI JL, Davies L, Haymart MR, Roman BR, et al
    Inappropriate use of radioactive iodine for low-risk papillary thyroid cancer is most common in regions with poor access to health care.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  131. BRAUNER E, Holmes BJ, Krane J, Nishino M, et al
    Performance of the Afirma Gene Expression Classifier in Hurthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  132. MOND M, Bullock M, Yao Y, Clifton-Bligh RJ, et al
    Somatic Mutations of FOXE1 in Papillary Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  133. HANLEY JP, Jackson E, Morrissey LA, Rizzo DM, et al
    Geospatial and Temporal Analysis of Thyroid Cancer Incidence in a Rural Population.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    April 2015
  134. KIM SM, Kim HK, Chang H, Kim KJ, et al
    Recovery from Permanent Hypoparathyroidism after Total Thyroidectomy.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  135. FRANCIS G, Waguespack SG, Bauer AJ, Angelos P, et al
    Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Pediatric Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  136. NAKAMURA H, Hirokawa M, Ota H, Kihara M, et al
    Is an increase in thyroid nodule volume a risk factor for malignancy?
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  137. MARTI JL, Jain KS, Morris LG
    Increased risks of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  138. YI KS, Kim JH, Na DG, Seo H, et al
    Usefulness of Core Needle Biopsy for Thyroid Nodules with Macrocalcifications: Comparison with Fine Needle Aspiration.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  139. WEISS RJ, Magner J
    Serial Measurements of Serum Thyroglobulin in Response to Recombinant Human Thyrotropin (rhTSH) Stimulation.
    Thyroid. 2015.
    PubMed     Text format    


  140. WU JX, Beni CE, Zanocco K, Sturgeon C, et al
    Cost-Effectiveness of Long-Term Every Three-Year Versus Annual Postoperative Surveillance for Low Risk Papillary Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    March 2015
  141. MORLEY S, Goldfarb M
    Support Needs and Survivorship Concerns of Thyroid Cancer Patients.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  142. RANDOLPH G, Sritharan N, Song P, Franco R, et al
    Thyroidectomy in the Professional Singer-Neural Monitored Surgical Outcomes.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  143. KEEGAN T, Grogan R, Parsons H, Tao L, et al
    Socio-demographic disparities in differentiated thyroid cancer survival among adolescents and young adults in California.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  144. KLOPPER J, Kane MA, Jimeno A, Sams S, et al
    A Phase II Trial of Bexarotene for Advanced Differentiated Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  145. HOANG JK, Langer JE, Middleton WD, Wu CC, et al
    Misinterpretation of the American College of Radiology White Paper on Managing Incidental Thyroid Nodules.
    Thyroid. 2015.
    PubMed     Text format    


  146. ROSARIO PW, Mourao GF, Siman TL, Calsolari MR, et al
    Serum thyroglobulin measured with a second-generation assay in patients undergoing total thyroidectomy without radioiodine remnant ablation: A prospective study.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  147. REMONTI LR, Kramer CK, Leitao CB, Pinto LC, et al
    Thyroid ultrasound features and risk of carcinoma: a systematic review and meta-analysis of observational studies.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  148. SEMRAD T, Semrad A, Farwell DG, Chen Y, et al
    Initial Treatment Patterns in Younger Adult Patients with Differentiated Thyroid Cancer in California.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  149. MEDAPATI MR, Dahlmann M, Ghavami S, Pathak KA, et al
    RAGE mediates the pro-migratory response of extracellular S100A4 in human thyroid cancer cells.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    February 2015
  150. HAYASE S, Sasaki Y, Matsubara T, Seo D, et al
    Expression of stanniocalcin 1 in thyroid side population cells and thyroid cancer cells.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  151. PERTICONE F, Pigliaru F, Mariotti S, Deiana L, et al
    IS THE INCIDENCE OF DIFFERENTIATED THYROID CANCER INCREASED IN PATIENTS WITH TSH-SECRETING ADENOMA? REPORT OF THREE CASES FROM A LARGE CONSECUTIVE SERIES OF TSH-OMA.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    January 2015
  152. NASCIMENTO C, Borget I, Al Ghuzlan A, Deandreis D, et al
    Post-operative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT): an important imaging modality in patients with aggressive histology of differentiated thyroid cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  153. CHAMI L, Hartl DM, Leboulleux S, Baudin E, et al
    PREOPERATIVE LOCALIZATION OF NECK RECURRENCES FROM THYROID CANCER: CHARCOAL TATTOOING UNDER ULTRASOUND GUIDANCE.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  154. CHOUGNET CN, Borget I, Leboulleux S, de la Fouchardiere C, et al
    Vandetanib for the treatment of advanced medullary thyroid cancer outside a trial: results from a French cohort.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  155. BURYK MA, Simons JP, Picarsic JL, Monaco SE, et al
    Can malignant thyroid nodules be distinguished from benign thyroid nodules in children and adolescents by clinical characteristics? A review of 89 pediatric patients with thyroid nodules.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  156. TUFANO R, Noureldine SI, Angelos P
    Ethical Responsibilities of Caring for Patients with Incidental Thyroid Nodules.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  157. FENG X, Milas M, O'Malley M, LaGuardia L, et al
    Characteristics of Benign and Malignant Thyroid Disease in Familial Adenomatous Polyposis Patients and Recommendations for Disease Surveillance.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  158. LYLE M, Dean D
    Ultrasound Guided Fine Needle Aspiration Biopsy of Thyroid Nodules in Patients taking Novel Oral Anticoagulants.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  159. SACKS W, Wong R, Bresee C, Braunstein G, et al
    Use of Evidence-Based Guidelines Reduces I131 Treatment in Patients with Low Risk Differentiated Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  160. ROGOUNOVITCH T, Bychkov A, Takahashi M, Mitsutake N, et al
    The common genetic variant rs944289 at chromosome 14q13.3 associates with risk of both malignant and benign thyroid tumors in Japanese population.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    December 2014
  161. BEUTNER U, Leowardi C, Bork U, Luthi C, et al
    Survival after renal cell carcinoma metastasis to the thyroid. Single center experience and systematic review of the literature.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


    November 2014
  162. NAGARAJAN N, Schneider EB, Ali SZ, Zeiger MA Md, et al
    How Do Liquid Based Preparations of Thyroid FNA Compare with Conventional Smears? An Analysis of 5475 Specimens.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: